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Optimization of reaction parameters for the 
electrochemical oxidation of lidocaine with a 
Design of Experiment approach 
dentification of potentially toxic oxidative drug metabolites is a crucial step in the development 
of new drugs. Electrochemical methods are useful to study oxidative drug metabolism, but are 
not widely used to synthesize metabolites for follow-up studies. Careful optimization of reaction 
parameters is important for scaling up the electrochemical synthesis of metabolites. In the present 
study, lidocaine was used as a drug compound in order to optimize electrochemical reaction parameters 
employing a design of experiments approach to improve the yield of N-dealkylated lidocaine, a major 
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The development of new drugs is a costly and time-consuming process. The detection and 
evaluation of possibly toxic oxidative drug metabolites at the early stages of drug discovery and 
development is therefore quite important [1–3]. Drug metabolism is initially studied in in vivo and in 
vitro experimental models, for example in human or animal liver microsomes [4,5]. However, these 
methods are not adequate to produce metabolites in sufficiently large quantities for follow-up studies 
[6]. In order to characterize the structure and study the toxicology of metabolites, it is necessary to 
have quantities in excess of 1 mg [7,8]. While organic synthesis is the standard approach, an emerging 
technique to produce oxidative metabolites is electrochemistry (EC), which can be combined with 
mass spectrometry (EC-MS) for product monitoring to optimize the conditions of metabolite synthesis 
[9,10]. 
 
Figure 1. Lidocaine and its major metabolites. 
The local anesthetic lidocaine (Figure 1) has been used as a model compound for the study of 
oxidative metabolism by electrochemistry. The in vivo reactions, catalyzed by enzymes of the 
cytochrome P450 family, are N-dealkylation and N-oxidation of the tertiary amine, aromatic 
hydroxylation at the 3 and 4 positions and benzylic hydroxylation (Figure 1) [11–14]. Previously, our 
group reproduced most of these reactions by various electrochemical approaches. Jurva et al. showed 
that direct electrochemical oxidation results in N-dealkylation of lidocaine [1]. Nouri-Nigjeh et al. 
showed further that indirect oxidation of lidocaine by electrochemically generated reactive oxygen 
species leads to N-oxide formation [15]. Moreover, aromatic hydroxylations were observed at high 
potentials (3 V or more) in acetonitrile/water (99:1) containing 0.1 M tetrabutylammonium perchlorate 
as background electrolyte [16]. In addition, Nouri-Nigjeh et al. showed that using square-wave potential 
pulses with long cycle times of around 1 s led to formation of the 4-hydroxylation product, but that 
short cycle times of 10 ms or less resulted in N-dealkylation [16]. Although various electrochemical 
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methods have been shown to produce different lidocaine metabolites, they were not optimized with 
respect to yield and reproducibility. Optimizing electrochemical synthetic methods is a multi-parameter 
problem with several interconnected factors affecting selectivity and yield. Electrochemical reaction 
parameters include substrate concentration, solvent, supporting electrolyte, pH, temperature, 
oxidation potential, potential cycle times, electrode material, flow rate (for flow-through cells) or 
reaction time (for batch cells) and cell dimensions. A better understanding of the effects of the reaction 
conditions is thus needed prior to scaling the synthesis up. 
Optimization of EC parameters has thus far mostly been done using on-line EC-MS with 
commercially available flow-through cells [5,10,17–26]. In these systems, drug molecules are prepared 
in solvents of different compositions at different pH values, and these samples are pumped through a 
flow-through cell at various flow rates. A potential ramp may be applied over a desired range, and the 
electroactive species monitored by mass spectrometry and identified from the recorded mass 
voltammograms. While convenient with respect to selecting the optimal potential, this approach is 
time-consuming when it comes to parameters such as solvent, pH and electrode material and notably 
for assessing interdependent parameters. In addition, on-line EC-MS limits the range of parameters, 
such as solvent, pH and electrolytes, since a compromise between MS and EC conditions must be 
found. The above-mentioned problems can be avoided by working off-line so that EC parameters can 
be optimized independent of the MS conditions [15,27–32]. 
In the present study, we used a multi-parametric optimization approach to increase yield and 
selectivity of electrochemical drug metabolite synthesis based on a Design of Experiments (DOE) 
strategy. A set of experiments was planned to obtain information about inter-parameter correlations 
and interactions from a limited number of experiments [33]. Lidocaine was used as model compound 
focusing on optimizing the yield of the N-dealkylation product. Our data show that reaction 
parameters such as pH and electrode material have a major effect on the final yield. 
3.2. Experimental procedures 
3.2.1. Reagents 
Lidocaine (L7757), monoethylglycinexylidide (MEGX, SML0087, the N-dealkylated form of 
lidocaine) and ammonium hydroxide (NH4OH, 221228) were purchased from Sigma-Aldrich. Formic 
acid (HCOOH, 94318) and acetaminophen (00370) were purchased from Fluka and ultra-pure HPLC 
grade acetonitrile (ACN, 01203502) was purchased from Biosolve. Trifluoroacetic acid (TFA, 289084) 
was purchased from Thermo Fisher, and sulfuric acid (H2SO4, 100731100) from Merck Millipore. 
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Ultrapure water was obtained from a Milli-Q Advantage A10 Water Purification system (Millipore 
Corp., Billerica, MA, USA). 
3.2.2. Electrochemical measurements 
All electrochemical measurements were performed with an Antec ROXY potentiostat (Antec 
Leyden, Zoeterwoude, The Netherlands) controlled by the Antec Dialogue software. Electrochemical 
reactions were performed in a one-compartment three-electrode cell in which the working electrodes 
were gold (MF-2014, 1.6 mm diameter, Bioanalytical System (BASi), West Lafayette, IN, USA), 
platinum (MF-2013, 1.6 mm diameter, BASi) or glassy carbon (GC) (MF-2012, 3.0 mm diameter, BASi) 
disk electrodes and the auxiliary electrode a platinum wire (MW-4130, BASi). Potentials were measured 
against a silver wire pseudo-reference electrode (MF-2017, BASi) to avoid possible chloride 
contamination from the traditional Ag/AgCl reference electrode during electrochemical oxidations. 
All electrochemical experiments were performed at ambient temperature, and for deaeration argon gas 
was bubbled at 20 mL/min via a sparge tube (MW-4145, BASi). Working electrodes surfaces were 
polished with a lapping sheet (Micromesh grade 3200) with a 0.05 μm alumina slurry, followed by 
sonication in deionized water, ethanol and water for 1 min each. After mechanical polishing, the 
electrode surface was washed with ethanol and dried with nitrogen.  
For acidic (pH 3) sample conditions, 10 M lidocaine solutions were prepared in 
ACN/H2O/formic acid (90/9.45/0.55), and 1000 M lidocaine solutions in ACN/H2O/formic acid 
(90/8/2). For basic (pH 12) conditions, 10 M and 1000 M lidocaine samples were prepared in 
ACN/NH4OH (90/10). For pH 8 and pH 10 conditions, 10 M lidocaine samples were prepared in 
ACN/H2O/NH4OH (90/9.992/0.008) and ACN/H2O/NH4OH (90/8/2), respectively. Unless 
mentioned otherwise, 1 mL solutions of lidocaine were oxidized at various conditions according to the 
DOE experimental plan. After electrochemical oxidation for 30 min, samples were diluted with water 
containing 100 M acetaminophen as internal standard (IS). For HPLC column compatibility, the basic 
sample (pH 12) was acidified to pH 3-4 with 10% formic acid in water. The final composition of the 
samples contained 1  lidocaine (based on the initial concentration) and 10 M acetaminophen for 
LC-MS analysis. 
3.2.3. Experimental design 
The MODDE v.9.1.1.0 software (MKS Umetrics AB, Stortorget, Sweden) was used to produce 
a D-optimal design in order to optimize the electrochemical reaction parameters. The D-optimal 
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design (determinant) is used for optimization problems that require coverage of a broad range of 
parameters with a minimal number of experiments while gathering a maximum amount of information 
[33]. For the lidocaine metabolite production, a two-step optimization strategy was pursued where the 
second step employed a full factorial design instead of a D-optimal design (Tables 1 and 2). 
3.2.4. LC-MS analysis 
LC-MS analyses were carried out on an LC-Packings Ultimate Plus HPLC system (LC-Packings, 
Amsterdam, the Netherlands) coupled to a Thermo Finnigan TSQ Quantum AM triple quadrupole 
mass spectrometer with an ESI interface in the positive mode (Thermo Finnigan, San José, CA). The 
MS parameters for the TSQ Quantum AM were as follows: spray voltage 4000 V, sheath gas pressure 
40, auxiliary gas pressure 20, capillary temperature 350 ºC, tube lens offset 90 V, skimmer offset -0 V, 
with scans between m/z 100-300 (scan time 1 s, Q1 peak width 0.70 amu FWHM). For selected 
reaction monitoring (SRM), 3 transitions were selected for lidocaine and its metabolites (lidocaine: 
235/86, N-dealkylation product: 207/58, aromatic hydroxylation products: 251/86). For the 
acetaminophen IS the transition 152/110 was selected. All SRM measurements were performed with 
a dwell time of 100 ms each and Q1 and Q3 peak widths of 0.70 amu FWHM. 
LC separations were performed with a C18 reversed-phase column (GraceSmart RP 18 5 m, 
2.1×150 mm; Grace Davison, Lokeren, Belgium) at a flow rate of 250 L/min. Solvent A was H2O 
with 0.1% formic acid, while solvent B was ACN with 0.1% formic acid. 20 L of the diluted oxidation 
product mixture were injected and a linear gradient was applied from 5 to 50 % B over 10 min, followed 
by an instant increase to 95% B, which was held for 2 min. The column was re-equilibrated at 5% A 
for 4 min. Acetaminophen IS was used to normalize the peak areas of lidocaine and its oxidation 
products, resulting in the normalized product yield shown in Figures 2 and 3. Normalized product 
yields obtained for experiments using the GC electrode were additionally corrected for its larger surface 








Table 1. Experimental plan for the first round of optimizations of the lidocaine N-dealkylation reaction 
conditions. The plan includes three replicates (Exp 21-23). The D-optimal experimental design with a 












Exp 1 23 3 10 Carbon 0.75 
Exp 2 10 3 1000 Carbon 0.75 
Exp 3 15 12 1000 Carbon 0.75 
Exp 4 12 3 10 Pt 0.75 
Exp 5 5 12 10 Pt 0.75 
Exp 6 11 3 1000 Pt 0.75 
Exp 7 9 12 1000 Pt 0.75 
Exp 8 14 3 10 Au 0.75 
Exp 9 1 12 10 Au 0.75 
Exp 10 16 3 1000 Au 0.75 
Exp 11 19 3 10 Carbon 1.50 
Exp 12 13 12 10 Carbon 1.50 
Exp 13 6 3 1000 Carbon 1.50 
Exp 14 7 3 10 Pt 1.50 
Exp 15 21 12 10 Pt 1.50 
Exp 16 3 3 1000 Pt 1.50 
Exp 17 17 12 1000 Pt 1.50 
Exp 18 8 3 10 Au 1.50 
Exp 19 18 3 1000 Au 1.50 
Exp 20 2 12 1000 Au 1.50 
Exp 21 4 12 1000 Au 1.50 
Exp 22 20 12 1000 Au 1.50 










Table 2. Experimental plan of the second round of optimizations. The experiments were performed  
in duplicate and cover the full set of parameter combinations (pH 8, 10, 12, and potential 0.75, 1.00, 
1.25 and 1.50 V) (including 3 replicates, Exp 13-15). 10 M lidocaine concentration and glassy carbon 
















3.3. Results and discussion 
3.3.1. Optimization of EC parameters 
Based on literature examples, the most important EC parameters for the electrochemical 
synthesis of drug metabolites are pH, substrate concentration, potential and electrode material [5,17–
20]. In order to investigate the effect of these parameters on the synthesis of N-dealkylated lidocaine 
systematically, a two-step optimization strategy was pursued, starting from a broad range of parameter 
levels. As mentioned in the Experimental Design section a D-optimal design was used to minimize the 
number of experiments while providing coverage of a broad parameter space. The LC-MS peak area 
of the N-dealkylation product was taken as output response. Other metabolites, namely the N-oxide 
and aromatic hydroxylation products, were also monitored but were either absent (hydroxylations) or 
obtained in low and irreproducible yields (N-oxide). Three continuous range factors, pH (3-12), 
concentration (10-1000 M), and potential (0.75-1.50 V) were defined as well as one a discrete factor, 








Exp 1 13 8 0.75 
Exp 2 12 10 0.75 
Exp 3 15 12 0.75 
Exp 4 9 8 1.00 
Exp 5 6 10 1.00 
Exp 6 10 12 1.00 
Exp 7 2 8 1.25 
Exp 8 5 10 1.25 
Exp 9 14 12 1.25 
Exp 10 1 8 1.50 
Exp 11 3 10 1.50 
Exp 12 4 12 1.50 
Exp 13 8 10 1.00 
Exp 14 7 10 1.00 
Exp 15 11 10 1.00 
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including three replicates of one randomly selected condition. LC-MS results of this first round of 
optimization are shown in Figure 2 revealing that by far the highest amount of N-dealkylation product 
was obtained in experiment 12 corresponding to a pH of 12 and a potential of 1.5 V in combination 
with a low starting concentration (10 M) and a glassy carbon electrode. Surprisingly, in most 
experiments where 1000 M starting concentrations were used the N-dealkylation product was 
obtained in relatively low yield or was even absent. Acidic conditions clearly produced lower yields, as 
evidenced by comparing experiments 11 and 12, which only differ in pH (3 and 12, respectively). This 
is interesting, since a large majority of electrochemical drug oxidation experiments reported in the 
literature were performed at acidic pH. 
The first-step optimization results encouraged us to investigate the effect of pH and potential 
on N-dealkylation of lidocaine in more detail as these appeared to be the most important parameters. 
In the second-step optimization, 10 M lidocaine and the GC electrode were used throughout and 
narrower ranges were defined for the pH (8, 10 and 12) and the oxidation potential (0.75, 1.00, 1.25 
and 1.50 V). A full set of fifteen parameter combinations was generated, including three replicates for 
one condition. The LC-MS results confirmed that high pH values and high oxidation potentials 
produced the highest amount of N-dealkylation product (Figure 3). As expected, the differences in 
yields were smaller, and no significant increase was observed between 1.25 and 1.5 V.  
Supporting electrolytes are required for conductivity, but their effect on the synthesis was not 
considered during optimization of the EC parameters. A control experiment was thus performed to 
verify whether the observed pH effect on N-dealkylation product yield could instead be explained by 
the difference in supporting electrolyte type and concentration. For this purpose, 10 M lidocaine was 
prepared at pH 3 in 90% ACN and 10% H2O (containing 10 mM NaCl and 1% FA) and at pH 12 in 
90% ACN and 10% (aq.) NH4OH (containing 10 mM NaCl). The samples were oxidized at 1.5 V 
using the glassy carbon electrode. LC-MS results of samples containing additional supporting 
electrolyte showed almost the same relative yield of the N-dealkylation product as samples without 
additional NaCl, at both pH 3 and 12. These results indicated that the use of additional electrolyte does 
not affect synthesis yield. 
Reproducibility of metabolite yield is rarely reported in studies of electrochemical drug oxidation, 
but is crucial for reliable optimization of conditions and further scale up. In our study one randomly 
chosen condition was measured in triplicate in both the first and second round of optimizations. In 
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addition, the entire second optimization was performed in duplicate. As indicated in Figures 2 and 3, 
the yields were reproducible to within +/- 18%.  
 
 
Figure 2. LC-MS results of the first round of optimizations of the DOE design indicating the relative 
yields of the N-dealkylation product of lidocaine under different experimental conditions (see Table 1 
for details). The experimental design included three replicates (Exp 21-23) which have an average 
normalized yield of 0.052, and a standard error of 0.005. Exp 12 (pH 12, 1.50 V, GC, 10 M) gave by 
far the highest yield. 
 
Figure 3. LC-MS results of the second round of optimizations (10 μM lidocaine, GC electrode) across 
a narrower range of parameter values (see Table 2 for details). All experiments were performed in 
duplicate and the error bars show the standard error. Exp 9 (pH 12, 1.25 V) gave the highest N-














































Figure 4. LC-MS in the SRM mode of lidocaine (235/86) at a) pH 3 (FA) and of the N-dealkylation 
product of lidocaine (207/58) after EC oxidation for 30 min using a glassy carbon electrode and 1.5 
V; b) pH 3 (FA), c) pH 1.5 (TFA), d) pH 0.5 (TFA), and e) pH 0.5 (H2SO4). At pH 0.5 the N-
dealkylation product of lidocaine was below the detection limit. 
3.3.2. pH effect on N-dealkylation   
The results of the optimization experiment can be rationalized by examining the N-dealkylation 
mechanism [15]. Salamone et al. proposed that hydrogen abstraction from the aliphatic C-H group 
adjacent to a basic group can be tuned depending on the strength of the added acid [34]. If lidocaine 
N-dealkylation is indeed initiated in this way, then acidic conditions should prevent N-dealkylation, 
whereas basic conditions should favor this reaction, as observed in our study. To investigate this 
further, we performed additional experiments at pH values between 0.5 and 3.0. 10 M lidocaine 
solutions were prepared in ACN/H2O/formic acid (90/9.45/0.55; pH 3.0), in ACN/H2O/TFA 
(90/9.45/0.55; pH 1.5), in ACN/H2O/TFA (90/5/5; pH 0.5) and oxidized for 30 min in a batch cell 
at 1.5 V using a GC working electrode. The LC-MS results showed that N-dealkylation is completely 
blocked at pH 0.5 while there is still some N-dealkylation at pH 1.5 (Figure 4 a-d). That this effect is 
not specific for TFA was confirmed by electrochemical oxidation of lidocaine in ACN/H2O/H2SO4 
(90/7.5/2.5; pH 0.5) showing that there was no N-dealkylation (Figure 4e). Strongly basic and acidic 



















































conditions have not previously been considered for drug metabolite synthesis by EC but are important 
to include in the parameter range for DOE optimization approaches. 
3.4. Conclusions 
The EC synthesis of the N-dealkylation product of lidocaine was optimized using a two-step 
DOE approach to efficiently cover a wide range of parameters. LC-MS in the selected reaction 
monitoring (SRM) mode was used to follow product formation in a sensitive and selective manner. 
We found that high pH and a high potential in combination with relatively low lidocaine concentrations 
and a glassy carbon electrode are most favorable for the synthesis of the N-dealkylation product. The 
relative yields under the most favorable conditions are still in the low percentage range but this is likely 
due to the small surface area of the electrode.  
High pH values, which are favorable for N-dealkylation, are not commonly used in the field of 
EC drug oxidation. The results can, however, be reconciled with the mechanistic view that abstraction 
of a hydrogen atom from the CH group adjacent to the tertiary amine is critical to initiate the N-
dealkylation reaction [33]. This proposed mechanism was confirmed by blocking the reaction 
completely at pH 0.5, well below the pH range initially used. Our data show that a multistep DOE 
strategy is an efficient approach to optimizing the many interacting parameters in EC-driven drug 
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